image description  

Efficacy of artesunate-amodiaquine (ASAQ) and artemether-lumefantrine (AL) fixed dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria in Nimba county, Liberia

  • 2010/01/01
Type de publication
  • Posters
  • Birgit Schramm
  • Parastou Valeh
  • Elisabeth Baudin
  • Charles S Mazinda
  • Richard Smith
  • Loretxu Pinoges
  • Timothy Sundaygar
  • Yah M Zolia
  • Joel J Jones
  • Eric Comte
  • Vincent Jullien
  • Gwenaelle Carn
  • Jean-René Kiechel
  • Elizabeth Ashley
  • Philippe J Guerin
  • Paludisme

Principal Objective:
- To evaluate the efficacy of ASAQ (ASAQ Winthrop®) and artemether-lumefantrine (AL) (Coartem®) in children 6-59 months suffering from uncomplicated Plasmodium falciparum (Pf) malaria.
Secondary Objectives
- To assess the safety of ASAQ and AL in 6-59 months old children by documenting adverse events
- To measure the pharmacokinetic (PK) of desethyl-amodiaquine and lumefantrine at day 0 and day 7 (bioavailability differences possibly influencing efficacy).